APPLICATION
NDA010585
TYPE
NDA
ORIGINAL APPROVAL
1957-08-15
LATEST ACTION
1978-08-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
LERITINEDiscontinued
ANILERIDINE HYDROCHLORIDE EQ 25MG BASE · TABLET · ORAL
Approval history
1978-08-18Labeling · Supplement 10AP
1975-11-24Labeling · Supplement 8AP
1975-03-31Labeling · Supplement 7AP
1957-08-15Type 1 - New Molecular Entity · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.